Pfizer and BioNTech announce the start of BNT162 vaccine trial

Pfizer and BioNTech announce the start of BNT162 vaccine trialPfizer and BioNTech announced the start of the BNT162 clinical trials on Tuesday, boosting confidence that a potential treatment or vaccine could be around the corner. Yahoo Finance’s Anjalee Khemlani joins The Final Round panel to break down the latest news about the coronavirus.




from Yahoo Finance https://ift.tt/2SF9Qtv

Post a Comment

0 Comments